EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cushing syndrome in paediatric population: who and how to screen

Laura Chioma, Giuseppa Patti, Marco Cappa, Mohamad Maghnie

Journal of Endocrinological Investigation · 30.09.2024 · 48 (S1) · 7-19

DOI: 10.1007/s40618-024-02452-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Endocrinological Investigation, online erschienen am 30.09.2024. Verfasst von Laura Chioma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Diabetology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Cushing Syndrome, Mass Screening. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cushing’s syndrome (CS) is characterised by signs and symptoms resulting from excessive and prolonged exposure to exogenous glucocorticoids or endogenous hypercortisolism. In childhood, exogenous CS represents the main cause of CS due to the widespread therapeutic use of glucocorticoids, while endogenous CS is very rare and accounts for about 10% of CS cases. According to the origin of the hypercortisolism, the ACTH-dependent form due to pituitary ACTH-secreting tumours is the most common form of endogenous CS in paediatric age (about 75–80% of cases), following by adrenal causes (about 15–20% of cases) including adenoma, carcinoma (which has a peak of incidence in the first decade), bilateral adrenal hyperplasia or Carney complex, with a different distribution by age. Ectopic ACTH-secreting CS, genetic forms of pituitary adenomas are more uncommon. The insidious onset of hypercortisolism and the absence of salient early signs make the diagnosis of endogenous CS difficult. Facial changes, weight gain with simultaneous growth failure, prepubertal virilisation, or hypogonadism in adolescence represent some of the key features of CS. The diagnostic workup is essentially aimed at confirming hypercortisolism through screening tests whose diagnostic accuracy is not 100% and therefore the combination of more than two tests is mandatory to confirm the diagnosis of CS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cushing SyndromeMass ScreeningHumansChildAdolescent

Stichwörter der Autor:innen

Cushing diseaseCushing syndromeDiagnosisPaediatric population

Autor:innen und Institutionen

  • Endocrinology and Diabetology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Research Unit for Innovative Therapies in Endocrinopathies, Bambino Gesù Children's Hospital, IRCCS, L.go Sant'Onofrio 4, Rome, 00165, Italy.
  • Department of Pediatrics, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
  • Research Unit for Innovative Therapies in Endocrinopathies, Bambino Gesù Children's Hospital, IRCCS, L.go Sant'Onofrio 4, Rome, 00165, Italy. marco.cappa@opbg.net.

Zitieren

APA

Chioma, L., Patti, G., Cappa, M., & Maghnie, M. (2024). Cushing syndrome in paediatric population: who and how to screen. Journal of Endocrinological Investigation, 48(S1), 7-19. https://doi.org/10.1007/s40618-024-02452-w

Vancouver

Chioma L, Patti G, Cappa M, Maghnie M. Cushing syndrome in paediatric population: who and how to screen. Journal of Endocrinological Investigation. 2024;48(S1):7-19. doi:10.1007/s40618-024-02452-w

BibTeX
@article{Chioma2024,
  author = {Chioma, Laura and Patti, Giuseppa and Cappa, Marco and Maghnie, Mohamad},
  title = {Cushing syndrome in paediatric population: who and how to screen},
  journal = {Journal of Endocrinological Investigation},
  year = {2024},
  volume = {48},
  number = {S1},
  pages = {7--19},
  doi = {10.1007/s40618-024-02452-w}
}
Kostenlos starten →